Page last updated: 2024-08-16

tibolone and tamoxifen

tibolone has been researched along with tamoxifen in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (10.71)18.2507
2000's18 (64.29)29.6817
2010's7 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dalvie, D; Loi, CM; Smith, DA1
de Chambine, S; Decroix, Y; Gompel, A; Jacob, D; Mimoun, M; Poitout, P; Rostene, W1
Christiansen, C1
Brouillet, JP; Maudelonde, T; Pujol, P1
Galid, A; Kubista, E; Seifert, M1
Ang, WC; Farrell, E; Vollenhoven, B1
Baker, RS; Clark, KE; Kopernik, G; Mershon, JL; Zoma, WD1
Bundred, N; Fentiman, IS; Foidart, JM; Helmond, FA; Kroiss, R; Kubista, E; Mol-Arts, M; Rymer, J1
Mijatovic, V; van der Mooren, MJ; Vogelvang, TE1
Czerny, B; Juzyszyn, Z; Myśliwiec, Z; Pawlik, A; Teister, M1
Albertazzi, P; Richmond, I; Sharma, S1
Herrington, DM; Lakoski, SG1
Baber, R; Hickey, M; Kwik, M1
Franke, HR; Vermes, I; Werner, HM1
Bredakis, N; Dimitrakakis, C; Gaki, V; Keramopoulos, A; Keramopoulos, D; Vourli, G1
Athayde, C; Correia, T; Coutinho, E; Freitas, LA; Maia, H1
Kluft, C1
Beckmann, MW; Bundred, NJ; Egberts, J; Foidart, JM; Kenemans, P; Kubista, E; Planellas, J; Sismondi, P; van Os, S; Vassilopoulou-Sellin, R; von Schoultz, B; Yip, CH1
Biberoglu, K; Celik, HH; Gürsoy, RH; Keskin, PO; Nas, T; Sargon, MF1
Neves-E-Castro, M1
Bentolila, J; Boisserie-Lacroix, M; Bouzgarrou, M; Cavagni, P; Laumonier, H; Lebiez-Michel, N; Trillaud, H1
Fu, R; Griffin, JC; Humphrey, L; Nelson, HD; Nygren, P; Smith, ME1
Arun, B; Brown, PH; Castiglione, M; Cuzick, J; DeCensi, A; Dunn, B; Forbes, JF; Glaus, A; Howell, A; Vogel, V; von Minckwitz, G; Zwierzina, H1
Biglia, N; Egberts, J; Kenemans, P; Kimmig, R; Kubista, E; Moggio, G; Mol-Arts, M; Mulder, R; Planellas, J; Sismondi, P1
Cucinella, L; Nappi, RE1
Castelo-Branco, C; Currie, H; Mijatovic, V; Nappi, RE; Palacios, S; Rees, M; Simon, J1
Briarava, M; Mocellin, S; Nitti, D; Pilati, P1
Altwerger, G; Black, J; Feinberg, J; Menderes, G; Ratner, E; Whicker, M1

Reviews

15 review(s) available for tibolone and tamoxifen

ArticleYear
[Action of SERM and SAS (tibolone) on breast tissue].
    Contraception, fertilite, sexualite (1992), 1999, Volume: 27, Issue:5

    Topics: Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Neoplasms, Hormone-Dependent; Norpregnenes; Receptors, Estrogen; Tamoxifen

1999
[Anti-estrogens, selective estrogen receptor modulators (SERM), tibolone: modes of action].
    Contraception, fertilite, sexualite (1992), 1999, Volume: 27, Issue:9

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Estrogen Receptor Modulators; Female; Humans; Norpregnenes; Selective Estrogen Receptor Modulators; Tamoxifen

1999
Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review.
    Climacteric : the journal of the International Menopause Society, 2001, Volume: 4, Issue:4

    Topics: Animals; Disease Models, Animal; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Uterine Neoplasms

2001
Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.
    Treatments in endocrinology, 2004, Volume: 3, Issue:2

    Topics: Aging; Animals; Arteriosclerosis; Cardiovascular Diseases; Cardiovascular System; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen

2004
Effects of oestrogen receptor-active compounds on lipid metabolism.
    Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:5

    Topics: Antineoplastic Agents; Bone Density Conservation Agents; Female; Humans; Lipid Metabolism; Male; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen

2005
Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.
    Drug safety, 2005, Volume: 28, Issue:12

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Clonidine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Behavior; Hot Flashes; Humans; Menopause; Norpregnenes; Paroxetine; Personal Health Services; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen

2005
Effects of hormone treatment on hemostasis variables.
    Climacteric : the journal of the International Menopause Society, 2007, Volume: 10 Suppl 2

    Topics: Administration, Oral; Administration, Topical; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Hemostasis; Humans; Inflammation; Norpregnenes; Progestins; Raloxifene Hydrochloride; Tamoxifen; Venous Thromboembolism

2007
Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
    Clinical obstetrics and gynecology, 2008, Volume: 51, Issue:3

    Topics: Estrogen Replacement Therapy; Estrogens; Female; Humans; Norpregnenes; Ovarian Neoplasms; Postmenopause; Progestins; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Uterine Neoplasms

2008
[Hormones and mammographic breast density].
    Journal de radiologie, 2008, Volume: 89, Issue:9 Pt 2

    Topics: Adult; Aged; Biopsy; Breast; Breast Neoplasms; Contraceptive Agents, Female; Diagnosis, Differential; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Hormones; Humans; Intrauterine Devices; Levonorgestrel; Mammography; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Sensitivity and Specificity; Tamoxifen

2008
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.
    Annals of internal medicine, 2009, Nov-17, Volume: 151, Issue:10

    Topics: Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Fractures, Bone; Humans; Norpregnenes; Raloxifene Hydrochloride; Stroke; Tamoxifen; Thromboembolism

2009
Preventive therapy for breast cancer: a consensus statement.
    The Lancet. Oncology, 2011, Volume: 12, Issue:5

    Topics: Anastrozole; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Consensus Development Conferences as Topic; Diphosphonates; Estrogen Receptor Modulators; Expert Testimony; Female; Fenretinide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Nitriles; Norpregnenes; Piperidines; Premenopause; Pyrrolidines; Raloxifene Hydrochloride; Retinoids; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Triazoles

2011
Advances in pharmacotherapy for treating female sexual dysfunction.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:6

    Topics: Buspirone; Clinical Trials, Phase III as Topic; Estrogens; Female; Humans; Menopause; Norpregnenes; Piperazines; Purines; Selective Estrogen Receptor Modulators; Sexual Behavior; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfonamides; Tamoxifen; Testosterone

2015
Update on management of genitourinary syndrome of menopause: A practical guide.
    Maturitas, 2015, Volume: 82, Issue:3

    Topics: Atrophy; Complementary Therapies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Laser Therapy; Menopause; Norpregnenes; Quality of Life; Selective Estrogen Receptor Modulators; Sexuality; Syndrome; Tamoxifen; Vagina; Vulva

2015
Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials.
    Journal of the National Cancer Institute, 2016, Volume: 108, Issue:2

    Topics: Adult; Aged; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Norpregnenes; Piperidines; Postmenopause; Primary Prevention; Pyrrolidines; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes

2016
Management of sexuality, intimacy, and menopause symptoms in patients with ovarian cancer.
    American journal of obstetrics and gynecology, 2017, Volume: 217, Issue:4

    Topics: Administration, Topical; Anabolic Agents; Body Image; Cognitive Behavioral Therapy; Depression; Estrogen Antagonists; Estrogens; Fatigue; Female; Hormone Replacement Therapy; Humans; Lubricants; Menopause, Premature; Norpregnenes; Ovarian Neoplasms; Pelvic Floor Disorders; Physical Therapy Modalities; Phytotherapy; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sexuality; Tamoxifen; Testosterone

2017

Trials

4 trial(s) available for tibolone and tamoxifen

ArticleYear
The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
    BJOG : an international journal of obstetrics and gynaecology, 2005, Volume: 112, Issue:2

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Endometrium; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Hyperhidrosis; Lipids; Mammography; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Pilot Projects; Postmenopause; Tamoxifen

2005
Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:4

    Topics: Adult; Aged; Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Mammography; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Prospective Studies; Tamoxifen

2005
Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial.
    Breast (Edinburgh, Scotland), 2007, Volume: 16 Suppl 2

    Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Autonomic Nervous System Diseases; Bone Density; Breast Neoplasms; Double-Blind Method; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Norpregnenes; Quality of Life; Survival Analysis; Tamoxifen; Treatment Outcome; Vasomotor System

2007
Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
    Maturitas, 2011, Volume: 70, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Atrophic Vaginitis; Breast Neoplasms; Climacteric; Contraindications; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Intention to Treat Analysis; Longitudinal Studies; Middle Aged; Norpregnenes; Postmenopause; Quality of Life; Surveys and Questionnaires; Tamoxifen

2011

Other Studies

9 other study(ies) available for tibolone and tamoxifen

ArticleYear
Which metabolites circulate?
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5

    Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations

2013
Sex steroid analogs.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1999, Volume: 9 Suppl 2

    Topics: Animals; Bone Resorption; Breast Neoplasms; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Hormones; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Risk; Tamoxifen

1999
The oestrogen receptor and its selective modulators in gynaecological oncology.
    European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 4

    Topics: Antineoplastic Agents, Hormonal; Cinnamates; Estrogen Antagonists; Female; Genital Neoplasms, Female; Humans; Norpregnenes; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Thiophenes; Toremifene

2000
Differential effects of selective estrogen receptor modulators and estrogens on mammary blood flow in the ovine.
    American journal of obstetrics and gynecology, 2002, Volume: 187, Issue:6

    Topics: Animals; Blood Flow Velocity; Blood Pressure; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Heart Rate; Kinetics; Mammary Glands, Animal; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sheep; Tamoxifen

2002
Effect of tamoxifen, raloxifen and tibolon on bile components in ovariectomized rats.
    European journal of obstetrics, gynecology, and reproductive biology, 2005, Apr-01, Volume: 119, Issue:2

    Topics: Animals; Bile; Bile Acids and Salts; Calcium; Chlorides; Cholesterol; Female; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Tamoxifen

2005
Vaginal polyps and hormones--is there a link? A case series.
    Maturitas, 2006, Feb-20, Volume: 53, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Polyps; Postmenopause; Premenopause; Retrospective Studies; Tamoxifen; Vaginal Diseases

2006
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
    Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3

    Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured

2005
Cyclooxygenase-2 expression in endometrial polyps during menopause.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 21, Issue:6

    Topics: Cyclooxygenase 2; Endometrium; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Gonadal Steroid Hormones; Humans; Ki-67 Antigen; Menopause; Norpregnenes; Polyps; Tamoxifen; Uterine Diseases

2005
Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
    Saudi medical journal, 2007, Volume: 28, Issue:12

    Topics: Aged; Case-Control Studies; Endometrium; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Tamoxifen

2007